Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Feb;31(2):574–579. doi: 10.1128/iai.31.2.574-579.1981

Colicin V production by clinical isolates of Escherichia coli.

D L Davies, F R Falkiner, K G Hardy
PMCID: PMC351347  PMID: 7012013

Abstract

Strains of Escherichia coli isolated from random fecal samples, urines of hospitalized and nonhospitalized patients who had urinary tract infections, and blood of patients with septicemia were examined for colicin V production. The percentage of ColV+ strains isolated from blood (31.6%) or from urines of hospitalized patients with urinary tract infections (26.2%) was significantly greater (P less than 0.01) than the percentage isolated from feces (13.6%). The colicin V immunity determinant of ColV,I-K94 conferred immunity to 26% of the type V colicins produced by clinical isolates. Of the ColV+ strains studied, 63.6% produced at least one other type of colicin.

Full text

PDF
574

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Binns M. M., Davies D. L., Hardy K. G. Cloned fragments of the plasmid ColV,I-K94 specifying virulence and serum resistance. Nature. 1979 Jun 28;279(5716):778–781. doi: 10.1038/279778a0. [DOI] [PubMed] [Google Scholar]
  2. Cohen S. N., Chang A. C., Hsu L. Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc Natl Acad Sci U S A. 1972 Aug;69(8):2110–2114. doi: 10.1073/pnas.69.8.2110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cooke E. M., Ewins S. P. Properties of strains of Escherichia coli isolated from a variety of sources. J Med Microbiol. 1975 Feb;8(1):107–111. doi: 10.1099/00222615-8-1-107. [DOI] [PubMed] [Google Scholar]
  4. Cooke E. M. Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons. J Pathol Bacteriol. 1968 Jan;95(1):101–113. doi: 10.1002/path.1700950112. [DOI] [PubMed] [Google Scholar]
  5. Davies J. K., Reeves P. Genetics of resistance to colicins in Escherichia coli K-12: cross-resistance among colicins of group A. J Bacteriol. 1975 Jul;123(1):102–117. doi: 10.1128/jb.123.1.102-117.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davies J. K., Reeves P. Genetics of resistance to colicins in Escherichia coli K-12: cross-resistance among colicins of group B. J Bacteriol. 1975 Jul;123(1):96–101. doi: 10.1128/jb.123.1.96-101.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Edén C. S., Hanson L. A., Jodal U., Lindberg U., Akerlund A. S. Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet. 1976 Sep 4;1(7984):490–492. [PubMed] [Google Scholar]
  8. Fredericq P., Smarda J. Complexité du facteur colicinogène B. Ann Inst Pasteur (Paris) 1970 Jun;118(6):767–774. [PubMed] [Google Scholar]
  9. HAMON Y. LES BACT'ERIOCINES. Ann Inst Pasteur (Paris) 1964 Nov;107:SUPPL–SUPPL:53. [PubMed] [Google Scholar]
  10. Kaijser B. Immunology of Escherichia coli: K antigen and its relation to urinary-tract infection. J Infect Dis. 1973 Jun;127(6):670–677. doi: 10.1093/infdis/127.6.670. [DOI] [PubMed] [Google Scholar]
  11. Males B. M., Stocker B. A. Escherichia coli K317, formerly used to define colicin group E2, produces colicin E7, is immune to colicin E2, and carries a bacteriophage-restricting conjugative plasmid. J Bacteriol. 1980 Nov;144(2):524–531. doi: 10.1128/jb.144.2.524-531.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Minshew B. H., Jorgensen J., Swanstrum M., Grootes-Reuvecamp G. A., Falkow S. Some characteristics of Escherichia coli strains isolated from extraintestinal infections of humans. J Infect Dis. 1978 May;137(5):648–654. doi: 10.1093/infdis/137.5.648. [DOI] [PubMed] [Google Scholar]
  13. Quackenbush R. L., Falkow S. Relationship between colicin V activity and virulence in Escherichia coli. Infect Immun. 1979 May;24(2):562–564. doi: 10.1128/iai.24.2.562-564.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Robbins J. B., McCracken G. H., Jr, Gotschlich E. C., Orskov F., Orskov I., Hanson L. A. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med. 1974 May 30;290(22):1216–1220. doi: 10.1056/NEJM197405302902202. [DOI] [PubMed] [Google Scholar]
  15. SMITH H. W. The haemolysins of Escherichia coli. J Pathol Bacteriol. 1963 Jan;85:197–211. doi: 10.1002/path.1700850119. [DOI] [PubMed] [Google Scholar]
  16. Silver R. P., Aaronson W., Sutton A., Schneerson R. Comparative analysis of plasmids and some metabolic characteristics of Escherichia coli K1 from diseased and healthy individuals. Infect Immun. 1980 Jul;29(1):200–206. doi: 10.1128/iai.29.1.200-206.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Smarda J., Obdrzálek V. Colicine Q. Zentralbl Bakteriol Orig. 1966 Aug;200(4):493–497. [PubMed] [Google Scholar]
  18. Smith H. W. A search for transmissible pathogenic characters in invasive strains of Escherichia coli: the discovery of a plasmid-controlled toxin and a plasmid-controlled lethal character closely associated, or identical, with colicine V. J Gen Microbiol. 1974 Jul;83(0):95–111. doi: 10.1099/00221287-83-1-95. [DOI] [PubMed] [Google Scholar]
  19. Smith H. W., Huggins M. B. Further observations on the association of the colicine V plasmid of Escherichia coli with pathogenicity and with survival in the alimentary tract. J Gen Microbiol. 1976 Feb;92(2):335–350. doi: 10.1099/00221287-92-2-335. [DOI] [PubMed] [Google Scholar]
  20. Stuart S. J., Greenwood K. T., Luke R. K. Hydroxamate-mediated transport of iron controlled by ColV plasmids. J Bacteriol. 1980 Jul;143(1):35–42. doi: 10.1128/jb.143.1.35-42.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Williams P. H. Novel iron uptake system specified by ColV plasmids: an important component in the virulence of invasive strains of Escherichia coli. Infect Immun. 1979 Dec;26(3):925–932. doi: 10.1128/iai.26.3.925-932.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES